Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0781
    -0.0013 (-0.12%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2624
    +0.0002 (+0.01%)
     
  • USD/JPY

    151.3610
    -0.0110 (-0.01%)
     
  • Bitcoin USD

    70,068.59
    -313.76 (-0.45%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Walgreen reports February SSS down 0.6%, total February sales $5.75B

Walgreens had February sales of $5.75B, a decrease of 2.2% from $5.88B for the same month in fiscal 2012. Excluding last February’s leap day, this year’s February sales increased 1.5%. Total front-end sales decreased 3.1% compared with the same month in fiscal 2012, and were flat when excluding last February’s leap day. Comparable store front-end sales decreased 1.4%, while customer traffic in comparable stores decreased 4.9% and basket size increased 3.5%. Sales in comparable stores decreased by 0.6% in February. Generic drug introductions in the last 12 months negatively impacted total comparable sales by 3.7 percentage points.

Advertisement